[Federal Register Volume 61, Number 115 (Thursday, June 13, 1996)]
[Notices]
[Page 30089]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 96-15056]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
National Heart, Lung, and Blood Institute; Notice of Closed
Meeting
Pursuant to Section 10(d) of the Federal Advisory Committee Act, as
amended (5 U.S.C. Appendix 2), notice is hereby given of the following
Heart, Lung, and Blood Special Emphasis Panel (SEP) meeting:
Name of SEP: Sickle Cell Disease Therapy.
Date: June 20-21, 1996.
Time: 7:30 p.m.
Place: Holiday Inn, Chevy Chase, 5522 Wisconsin Avenue, Chevy
Chase, Maryland 20815.
Contact Person: Ivan Baines, Ph.D., Two Rockledge Center, Room
7184, 6701 Rockledge Drive, Bethesda, MD 20892-7924, (301) 435-0277.
Purpose/Agenda: To review and evaluate grant applications.
The meeting will be closed in accordance with the provisions set
forth in secs. 552b(c)(4) and 552b(c)(6), Title 5, U.S.C.
Applications and/or proposals and the discussions could reveal
confidential trade secrets or commercial property such as patentable
material and personal information concerning individuals associated
with the applications and/or proposals, the disclosure of which
would constitute a clearly unwarranted invasion of personal privacy.
This notice is being published less than fifteen days prior to the
meeting due to the urgent need to meet timing limitations imposed by
the review and funding cycle.
(Catalog of Federal Domestic Assistance Programs Nos. 93.837, Heart
and Vascular Diseases Research; 93.838, Lung Diseases Research; and
93.839, Blood Diseases and Resources Research, National Institutes
of Health)
Dated: June 10, 1996.
Susan K. Feldman,
Committee Management Officer, NIH.
[FR Doc. 96-15056 Filed 6-12-96; 8:45 am]
BILLING CODE 4140-01-M
